Japan
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 28.17 B
|
March 31, 2024 | USD 27.12 | 0.10% |
|
Japan |
|
2 |
USD 23.51 B
|
March 31, 2024 | USD 15.05 | -0.63% |
|
Japan |
|
3 |
USD 18.89 B
|
March 31, 2024 | USD 13.71 | -0.73% |
|
Japan |
|
4 |
USD 15.77 B
|
March 31, 2024 | USD 31.25 | -0.69% |
|
Japan |
|
5 |
USD 10.60 B
|
March 31, 2024 | USD 9.76 | -1.53% |
|
Japan |
|
6 |
USD 10.58 B
|
March 31, 2024 | USD 27.56 | -3.63% |
|
Japan |
|
7 |
USD 9.76 B
|
March 31, 2024 | USD 27.69 | -1.34% |
|
Japan |
|
8 |
USD 8.11 B
|
Feb. 29, 2024 | USD 14.39 | -0.85% |
|
Japan |
|
9 |
USD 7.88 B
|
Dec. 31, 2023 | USD 43.39 | 5.16% |
|
Japan |
|
10 |
USD 7.66 B
|
March 31, 2024 | USD 4.06 | 0.22% |
|
Japan |
|
11 |
USD 7.30 B
|
March 31, 2024 | USD 20.12 | -0.87% |
|
Japan |
|
12 |
USD 6.76 B
|
March 31, 2024 | USD 14.83 | -0.95% |
|
Japan |
|
13 |
USD 6.53 B
|
May 31, 2024 | USD 61.25 | 0.14% |
|
Japan |
|
14 |
USD 6.19 B
|
March 31, 2024 | USD 15.25 | -1.27% |
|
Japan |
|
15 |
USD 6.13 B
|
May 31, 2024 | USD 46.78 | -2.70% |
|
Japan |
|
16 |
USD 6.09 B
|
March 31, 2024 | USD 18.88 | -4.20% |
|
Japan |
|
17 |
USD 4.97 B
|
March 31, 2024 | USD 27.09 | -1.08% |
|
Japan |
|
18 |
USD 4.96 B
|
Feb. 29, 2024 | USD 17.40 | -0.57% |
|
Japan |
|
19 |
USD 4.90 B
|
March 31, 2024 | USD 29.77 | -0.89% |
|
Japan |
|
20 |
USD 4.17 B
|
March 31, 2024 | USD 13.67 | -2.04% |
|
Japan |
|
21 |
USD 3.88 B
|
March 31, 2024 | USD 7.64 | -1.09% |
|
Japan |
|
22 |
USD 3.88 B
|
March 31, 2024 | USD 9.35 | -1.03% |
|
Japan |
|
23 |
USD 3.38 B
|
March 31, 2024 | USD 29.12 | 0.44% |
|
Japan |
|
24 |
USD 3.32 B
|
March 31, 2024 | USD 10.39 | -0.80% |
|
Japan |
|
25 |
USD 3.13 B
|
Dec. 31, 2023 | USD 14.95 | -1.71% |
|
Japan |
|
26 |
USD 3.05 B
|
March 31, 2024 | USD 19.21 | -1.38% |
|
Japan |
|
27 |
USD 2.87 B
|
March 31, 2024 | USD 14.75 | -0.46% |
|
Japan |
|
28 |
USD 2.78 B
|
May 31, 2024 | USD 21.33 | 0.54% |
|
Japan |
|
29 |
USD 2.53 B
|
April 30, 2024 | USD 30.20 | 0.44% |
|
Japan |
|
30 |
USD 2.34 B
|
March 31, 2024 | USD 6.71 | -0.97% |
|
Japan |
|
31 |
USD 2.25 B
|
March 31, 2024 | USD 8.63 | -1.10% |
|
Japan |
|
32 |
USD 2.21 B
|
March 31, 2024 | USD 5.33 | -0.22% |
|
Japan |
|
33 |
USD 1.89 B
|
March 31, 2024 | USD 17.14 | -1.51% |
|
Japan |
|
34 |
USD 1.62 B
|
June 30, 2024 | USD 5.75 | -2.34% |
|
Japan |
|
35 |
USD 1.58 B
|
March 31, 2024 | USD 9.15 | -1.97% |
|
Japan |
|
36 |
USD 1.51 B
|
March 31, 2024 | USD 19.43 | -1.89% |
|
Japan |
|
37 |
USD 1.47 B
|
March 31, 2024 | USD 14.30 | -1.12% |
|
Japan |
|
38 |
USD 1.19 B
|
March 31, 2024 | USD 9.47 | -2.44% |
|
Japan |
|
39 |
USD 1.17 B
|
March 31, 2024 | USD 12.96 | -0.41% |
|
Japan |
|
40 |
USD 1.15 B
|
June 30, 2024 | USD 20.26 | -6.39% |
|
Japan |
|
41 |
USD 996.63 M
|
March 31, 2024 | USD 29.51 | -0.48% |
|
Japan |
|
42 |
USD 979.52 M
|
March 31, 2024 | USD 24.26 | -0.77% |
|
Japan |
|
43 |
USD 948.18 M
|
Feb. 29, 2024 | USD 12.40 | -1.00% |
|
Japan |
|
44 |
USD 944.61 M
|
Feb. 29, 2024 | USD 28.70 | -1.67% |
|
Japan |
|
45 |
USD 927.11 M
|
March 31, 2024 | USD 43.36 | -1.17% |
|
Japan |
|
46 |
USD 892.86 M
|
March 31, 2024 | USD 3.06 | 0.05% |
|
Japan |
|
47 |
USD 789.75 M
|
March 31, 2024 | USD 9.48 | -0.72% |
|
Japan |
|
48 |
USD 762.19 M
|
March 31, 2024 | USD 2.59 | -0.09% |
|
Japan |
|
49 |
USD 738.19 M
|
June 30, 2024 | USD 12.49 | 0.87% |
|
Japan |
|
50 |
USD 679.76 M
|
March 31, 2024 | USD 21.75 | -2.32% |
|
Japan |
The Healthcare company in Japan with the highest Revenue is Takeda Pharmaceutical Company Limited (Tokyo Stock Exchange: 4502.T) at USD 28.17 B.
The Healthcare company in Japan with the lowest Revenue is StemRIM (Tokyo Stock Exchange: 4599.T) at USD 0.00.
The top 10 Healthcare companies in Japan by Revenue are Takeda Pharmaceutical Company Limited, MediPal Holdings Corporation, Alfresa Holdings Corporation, Suzuken Co., Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Limited, Toho Holdings Co., Ltd., Welcia Holdings Co., Ltd., Chugai Pharmaceutical Co., Ltd. and Konica Minolta, Inc..
The bottom 10 Healthcare companies in Japan by Revenue are StemRIM, SanBio Company Limited, BrightPath Biotherapeutics Co., Ltd., Oncolys BioPharma Inc., NanoCarrier Co., Ltd., OncoTherapy Science, Inc., Welby Inc., Solasia Pharma K.K., MEDINET Co., Ltd. and Carna Biosciences, Inc..